Astrazeneca (AZN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended December 2024, Astrazeneca (AZN) reported revenue of $14.89 billion, up 23.8$1.05, compared to $0.73 in the year-ago quarter.The reported revenue represents a surprise of +4.26$14.28 billion. With the consensus EPS estimate being $1.07, the EPS surprise was -1.87%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street e ...